Statistics for Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Total visits

views
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction 14

Total visits per month

views
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 14
July 2024 0

File Visits

views
Pembrolizumab in Combination with Neoadjuvant.pdf 2

Top country views

views
Chile 14

Top city views

views
Santiago 14